Network·Venture Capital
📍 PHILADELPHIA, PA
SEC CRD #801-124768
New Rhein applies a private equity investment approach to life sciences venture capital investing, with a focus on later-stage, de-risked assets with proven clinical safety and efficacy. The firm targets product development execution and strategic exits as primary drivers of investment returns.
/S/ SUBHANU SAXENA
MANAGING PARTNER AND CHIEF COMPLIANCE OFFICER
📞 (201) 674-9387
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
AUM
$291M
Location
PHILADELPHIA, PA
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.